Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that it has priced a firm commitment underwritten public offering of 10,275,000 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE